Circassia Pharmaceuticals Plc Director/PDMR Shareholding (3073L)

TIDMCIR

RNS Number : 3073L

Circassia Pharmaceuticals Plc

17 July 2017

Persons Discharging Managerial Responsibilities / persons closely associated with them (PDMR) Notification

17 June 2017: Circassia Pharmaceuticals plc (LSE: CIR).

1 - Details of the person discharging managerial responsibilities/person closely associated

 
 Name   Steven Harris 
-----  -------------- 
 

2 - Reason for the notification

 
 Position/status                   Chief Executive Officer 
                                    (PDMR) 
--------------------------------  ------------------------ 
 Initial notification/amendment*   Initial Notification 
--------------------------------  ------------------------ 
 In case of amendment,             N/A 
  please enter the previous 
  notification reference 
  number and explain the 
  error that this notification 
  needs amending 
--------------------------------  ------------------------ 
 

3 - Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 
 Full name of entity*      Circassia Pharmaceuticals 
                            plc 
------------------------  -------------------------- 
 Legal Entity Identifier   2138006YAT138TOGA556 
  code 
------------------------  -------------------------- 
                           In accordance with ISO 
                            1744 LEI code 
------------------------  -------------------------- 
 

4 - Details of the transaction(s)

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted

 
   Date          Description of       Aggregated   Aggregated      Total 
              Financial Transaction      Price       Volume      Aggregated 
                                                                   Price 
----------  -----------------------  -----------  -----------  ------------ 
 17-Jun-17   Exercise of options      GBP0.0008     535,375      GBP428.30 
              under the 2007 
              EMI scheme without 
              sale of shares 
              (options issued 
              under 2007 EMI 
              scheme expire 
              10 years following 
              grant) 
----------  -----------------------  -----------  -----------  ------------ 
 
   i.          Exercise of options 
 
 Description of the financial      Circassia Holdings Ltd 
  instrument, type of instrument    2007 Unapproved Option 
                                    Scheme 
--------------------------------  ----------------------------------- 
 Identification Code               GB00BJVD3B28 
--------------------------------  ----------------------------------- 
 Nature of the transaction         Exercise of options 
--------------------------------  ----------------------------------- 
 Currency                          GBP 
--------------------------------  ----------------------------------- 
 Price(s) and Volume (s)              Price      Volume      Total 
                                    -----------  --------  ---------- 
                                     GBP0.0008p   535,375   GBP428.30 
                                    -----------  --------  ---------- 
--------------------------------  ----------------------------------- 
 Aggregated Information               Price      Volume      Total 
                                    -----------  --------  ---------- 
                                     GBP0.0008p   535,375   GBP428.30 
                                    -----------  --------  ---------- 
--------------------------------  ----------------------------------- 
 Date of Transaction               17 June 2017 
--------------------------------  ----------------------------------- 
 Place of Transaction              London: XLON 
--------------------------------  ----------------------------------- 
 
 
 For further information, please contact: 
 Circassia Pharmaceuticals plc 
  Julien Cotta, Company Secretary      [phone] 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHBRGDRCBBBGRR

(END) Dow Jones Newswires

July 17, 2017 13:28 ET (17:28 GMT)